NCT07207863 Tianshan Community Cohort Establishment and Follow-up
| NCT ID | NCT07207863 |
| Status | Recruiting |
| Phase | — |
| Sponsor | People's Hospital of Xinjiang Uygur Autonomous Region |
| Condition | Cohort Study |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000,000 participants |
| Start Date | 2016-01-01 |
| Primary Completion | 2035-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000,000 participants in total. It began in 2016-01-01 with a primary completion date of 2035-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This population-based cohort study on disease prevention and health promotion was established in northwest China, leveraging data from routine annual health examinations. Initiated in January 2016, the cohort enrolled nearly all residents aged 18 years and older who were registered at community healthcare centers. The program was developed to provide a comprehensive framework for disease prevention and community health promotion, with the aim of producing population-based evidence across a broad spectrum of diseases in the general population. At baseline, data were collected on participant demographics, medical and family histories, disability status, living environment, and blood biochemical parameters. Follow-up information is primarily obtained through chronic disease management programs, annual health examinations, and electrical health records. Cause-specific mortality is ascertained from local death registration systems. Biological specimens, questionnaire data, and electrical health records are systematically archived in the Biobank and Big Data Center of the People's Hospital of Xinjiang Uygur Autonomous Region.
Eligibility Criteria
Inclusion Criteria: 1. Residents \>=18y 2. Permanent residents or individuals who have lived in the region for more than 5 years and are enrolled in local social security medical insurance 3. Residents without severe physical disability and capable of normal communication 4. Residents whose diseases and deaths are monitored and managed by the local health authorities 5. Residents who voluntarily participate and provide written informed consent Exclusion Criteria: 1. Temporary residents or floating population 2. Residents with severe health conditions that prevent participation in the study 3. Residents who are unwilling to undergo follow-up assessments for the study
Contact & Investigator
Yining Yang, Prof.
PRINCIPAL INVESTIGATOR
People's Hospital of Xinjiang Uygur Autonomous Region
Frequently Asked Questions
Who can join the NCT07207863 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cohort Study. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07207863 currently recruiting?
Yes, NCT07207863 is actively recruiting participants. Contact the research team at tina0627@126.com for enrollment information.
Where is the NCT07207863 trial being conducted?
This trial is being conducted at Ürümqi, China.
Who is sponsoring the NCT07207863 clinical trial?
NCT07207863 is sponsored by People's Hospital of Xinjiang Uygur Autonomous Region. The principal investigator is Yining Yang, Prof. at People's Hospital of Xinjiang Uygur Autonomous Region. The trial plans to enroll 1,000,000 participants.